Effectiveness of binders in wet granulation: A comparison using model formulations of different tabletability

被引:29
作者
Becker, D [1 ]
Rigassi, T [1 ]
BauerBrandl, A [1 ]
机构
[1] UNIV FREIBURG,D-79104 FREIBURG,GERMANY
关键词
D O I
10.3109/03639049709150550
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Based on an analysis of model granulates and tablets, a comparison was made of the effectiveness of the binders PVP K30 PH, Cellulose HP-M 603, Lycatab DSH, Lycatab, PGS, and L-HPC (type LH II). A high shear mixer was used to prepare two model granulates (placebo and paracetamol) under processing conditions which were, as far as possible, comparable. The binders were added as proportions of 2%, 6%, and 10%. Water was used as the granulating liquid. The properties of the placebo granulates (particle size distribution, bulk and tapped density, granule strength, flow properties), and those of the tablets (crushing strength, friability) prepared from these granulates under different compaction forces, were generally good. However, with PVP, Cellulose HP-M603, and Lycatab, the disintegration time of the tablets did not meet pharmacopoeial requirements el)en though a ''disintegrant'' was used in the ''outer phase.'' The paracetamol formulations were prime examples of high-dose drug substances with particularly poor granulating and tabletting properties, well suited to reveal differences between the binders. The paracetamol granulates were of higher friability and less flowability than the placebo granulates. The tablets tended to cap, friability was (with few exceptions) high, and disintegration times were long. In the preparation of model tablets containing paracetamol, PVP K30 PH (6%), and Cellulase HP-M 603 (6%) turn out to be the binders of choice with respect to crushing strength, but the disintegration times are too long. Lycatab PGS, Lycatab DSH, and L-HPC-LH II could nor be used to produce paracetamol tablets that met the requirements.
引用
收藏
页码:791 / 808
页数:18
相关论文
共 15 条
[1]  
ACQUIER R, 1992, PHARM ACTA HELV, V67, P315
[2]  
ALONZO GD, 1990, DRUG DEV IND PHARM, V16, P1931
[3]  
*BPI, ROT LIST 1996
[4]   GRANULATION AND COMPACTION OF A MODEL SYSTEM .1. GRANULE PROPERTIES [J].
CUTT, T ;
FELL, JT ;
RUE, PJ ;
SPRING, MS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 33 (1-3) :81-87
[5]  
DELACOURTE A, 1992, PHARM ACTA HELV, V67, P308
[6]  
HELD VK, 1993, PHARM IND, V55, P171
[7]  
HORISAWA E, 1993, CHEM PHARM BULL, V41, P1428
[8]   MECHANICAL-PROPERTIES OF MOIST AGGLOMERATES IN RELATION TO GRANULATION MECHANISMS .2. EFFECTS OF PARTICLE-SIZE DISTRIBUTION [J].
KRISTENSEN, HG ;
HOLM, P ;
SCHAEFER, T .
POWDER TECHNOLOGY, 1985, 44 (03) :239-247
[9]  
SOYEUX P, 1994, STP PHARMA SCI, V4, P324
[10]   COMPARATIVE-EVALUATION OF 2 PHARMACEUTICAL BINDERS IN THE WET GRANULATION OF HYDROCHLOROTHIAZIDE LYCATAB(TM) DSH VERSUS KOLLIDON(R)-30 [J].
SYMECKO, CW ;
ROMERO, AJ ;
RHODES, CT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (10) :1131-1141